The Impact of the COVID-19 Pandemic on Diabetes Management

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1503 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-04-09

Study Completion Date

2022-09-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The "CoDiaM study" examines how diabetes management and outcomes are changing during the COVID-19 pandemic and whether these changes are influenced by socio-demographic factors, health literacy, self-efficacy and perceived social support.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Tele-interventions During the COVID-19 Pandemic in Patients With Diabetes Mellitus

NCT04344210

COVID Diabetes Mellitus, Type 2 Diabetes Mellitus, Type 1

COMPLETED NA

Structured Diabetes Self-Management Education and Care Outcomes in Adults liVIng With Type 2 Diabetes in Accra, Ghana

NCT04780425

Diabetes Mellitus, Type 2

COMPLETED NA

Diabetes Nutrition Education With Glycemic Control

NCT04440319

Type2 Diabetes Mellitus

COMPLETED NA

COVID-19 Glycemic Control Study

NCT05977205

Type 1 Diabetes Type 2 Diabetes

COMPLETED

Social Media-Delivered Patient Education in Enhancing Type 2 Diabetics Self-Management and Attitudes During the COVID-19 Pandemic

NCT04876274

Type 2 Diabetes

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Covid-19 pandemic created new challenges for patients with diabetes and their treating physicians. In order to protect people from SARS-COV-2 infections, social contacts were reduced by restrictions on many areas of social life. As a side effect, these measures could have also led to changes in the self-management of patients with diabetes mellitus, such as lack of physical exercise, less healthy dietary behavior, and a reduced intensity of medical care. These possible changes may be associated with poorer control of blood glucose, cholesterol, and blood pressure. Therefore, the CoDiaM study will investigate how management and outcomes of diabetes are changing during the pandemic and identify associated factors.

The study is based on data of patients treated in three GP practices specialized on diabetes treatment in Hamburg, Germany. Data collection will include a written patient survey and extraction of clinical data from patient records. The patient's survey includes sociodemographic data and validated instruments to assess diabetes self-management (DSMQ), health literacy (HLS-EU-Q16), self-efficacy (General Self-efficacy scale) and perceived social support (F-SozU K14). Data will be analyzed by descriptive statistics and multivariable, multilevel linear and logistic regression analyses adjusted for possible confounders and random effects on the practice level.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Type 2 Diabetes Type 1 Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with diabetes mellitus

Approximately 750 patients with diabetes mellitus from 3 GP practices specialized on diabetes treatment

No intervention

Intervention Type OTHER

Care as usual

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No intervention

Care as usual

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* being 18 years or older, and
* having diabetes type 2 or type 1, and
* having consulted the practice at least once in 2019 AND at least once in 2020

Exclusion Criteria

* no capacity to consent (e.g. because of dementia)
* insufficient German language skills to understand the questions in the questionnaire
* not able to fill out the questionnaire (e.g. because of blindness)
* gestational diabetes

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No